Fig. 2From: Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?A CARs structure. CD3zeta—stimulatory domain, 4-1BB—costimulatory domains; B receptor binding domains—scFv—single-chain variable fragments, Fab—antigen-binding fragment, Nb—nanobodyBack to article page